These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 11019923)

  • 1. HLA-B*4012: a new allele with unique serological features.
    Elsner HA; O'Brien BJ; Bryan CF; Meyer JA; Diederich DA; Pierce GE; Lau M; Terasaki PI; Blasczyk R
    Tissue Antigens; 2000 Aug; 56(2):180-3. PubMed ID: 11019923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional characterization and exon 2-intron 2-exon 3 gene sequence of HLA-B*2712 as found in a British family.
    Hemmatpour SK; Dunn PP; Evans PR; Green A; Howell WM
    Eur J Immunogenet; 1998 Dec; 25(6):395-402. PubMed ID: 9949944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel allele HLA-B*7805 in a Japanese female.
    Sekimoto T; Araseki M; Sato S; Sakaya S; Kato T; Ikeda H
    Tissue Antigens; 2001 Nov; 58(5):345-8. PubMed ID: 11844148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and serological characterization of HLA-B71 in association with different class I haplotypes or in different ethnic groups.
    Rodriguez SG; Bei M; Inamdar A; Stewart D; Johnson AH; Hurley CK
    Tissue Antigens; 1996 Jan; 47(1):58-62. PubMed ID: 8929713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization a novel HLA-B40 allele with serological Bw4 motif, HLA-B*4047, in the Finnish population and confirmation of B*270503 allele.
    Peräsaari JP; Koskela S; Partanen J
    Tissue Antigens; 2004 Jun; 63(6):595-7. PubMed ID: 15140040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence-based typing of exons 1-5 of a new HLA-B allele, B*3927*.
    Voorter CE; van den Berg-Loonen EM
    Tissue Antigens; 2004 May; 63(5):480-3. PubMed ID: 15104681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel HLA-B*40 allele and novel exon 1 sequences of two B*40 alleles identified in potential marrow donors.
    Gourley IS; Wu J; Bassinger S; Montoya GD; Yee J; Griffith BB; Kearns J; McKeen M; Birkos S; Williams TM; Kamoun M
    Tissue Antigens; 2000 Apr; 55(4):374-7. PubMed ID: 10852391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The recombinant HLA-B*5518 allele supports the evidence of conserved haplotype association of rare alleles.
    Lebedeva TV; Huang A; Ohashi M; Sibilia P; Alosco SM; Kempenich J; Yu N
    Tissue Antigens; 2005 Aug; 66(2):156-9. PubMed ID: 16029440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-B*44:138Q: Evidence for a confined deletion and recombination events in an otherwise unaffected HLA-haplotype.
    Faé I; Wenda S; Grill C; Fischer GF
    HLA; 2019 Feb; 93(2-3):89-96. PubMed ID: 30488584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-B*1559: a hybrid allele including exon 2 of HLA-B35 and exon 3 of HLA-B15 and serologically typed as B35.
    Magira E; Beznik-Cizman B; Monos D
    Tissue Antigens; 2000 Nov; 56(5):460-2. PubMed ID: 11144297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the novel allele HLA-B*1546 which belongs to the serological B72 type: implications for bone marrow transplantation.
    Elsner HA; Wölpl A; Goldmann SF; Blasczyk R
    Tissue Antigens; 2000 Jan; 55(1):83-5. PubMed ID: 10703618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single amino acid exchange shifts the serological reactivity of the novel HLA-B*4442 allele product from HLA-B44 to HLA-B21.
    Mrazek F; Fae I; Ambruzova Z; Raida L; Kriegova E; Indrak K; Fischer GF; Petrek M
    Int J Immunogenet; 2006 Jun; 33(3):197-200. PubMed ID: 16712651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nonsense mutation in exon 3 results in the HLA-B null allele B*5127N.
    Hou JY; Luning Prak E; Kearns J; Wu J; Bassinger S; Birkos S; Williams TM; Kamoun M
    Tissue Antigens; 2002 Sep; 60(3):262-5. PubMed ID: 12445310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence, genetics and serology of a new HLA-B allele: B*4903.
    Darke C; Street J; Guttridge MG
    Tissue Antigens; 2001 May; 57(5):478-80. PubMed ID: 11556975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural heterogeneity in HLA-B70, a high-frequency antigen of black populations.
    Domena JD; Little AM; Madrigal AJ; Hildebrand WH; Johnston-Dow L; du Toit E; Bias WB; Parham P
    Tissue Antigens; 1993 Nov; 42(5):509-17. PubMed ID: 8146861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant expression of HLA-B*3565Q is associated with a disrupted disulfide bond.
    Elsner HA; Horn PA; Schoenemann C; Altermann WW; Blasczyk R
    Immunogenetics; 2006 Nov; 58(11):929-31. PubMed ID: 17021858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a new HLA-B*39 allele: HLA-B*3924.
    Cook JT; Day S; Dunn PP; Welsh KI; Bunce M
    Tissue Antigens; 2000 Aug; 56(2):178-9. PubMed ID: 11019922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unexpected Bw4 and Bw6 reactivity patterns in new alleles.
    Voorter CE; van der Vlies S; Kik M; van den Berg-Loonen EM
    Tissue Antigens; 2000 Oct; 56(4):363-70. PubMed ID: 11098937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the new allele B*3556 and extension of the sequences of B*4420 and B*4427.
    Voorter CE; Gervais T; Mulkers EM; Latinne D; van den Berg-Loonen EM
    Tissue Antigens; 2006 Sep; 68(3):253-6. PubMed ID: 16948648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The novel allele HLA-B*35:167 differs from HLA-B*35:03:01 by the amino acid exchange Val152Glu.
    Gras C; Immenschuh S; Eiz-Vesper B; Blasczyk R; Figueiredo C
    Tissue Antigens; 2012 Feb; 79(2):135-7. PubMed ID: 22082086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.